Zejing Pharmaceuticals (688266.SH) submitted an application for the issuance and listing of H shares on the Hong Kong Stock Exchange and published the application materials.

Zejing Pharmaceuticals (688266.SH) announced that on December 19, 2025, the company submitted an application to the Hong Kong Stock Exchange to issue H shares and list them on the Main Board of the Hong Kong Stock Exchange. On the same day, the application materials for this issuance were published on the Hong Kong Stock Exchange website. The application materials were prepared and published in accordance with the requirements of the Securities and Futures Commission of Hong Kong (referred to as the "Hong Kong Securities and Futures Commission") and the Hong Kong Stock Exchange, and are draft versions. The information contained therein may be updated and revised in a timely manner, and investors should not make any investment decisions based on the information therein.